$ARTL
ARTELO BIOSCIENCES, INC.

2020 Q4 Form 10-Q Financial Statement

#000164033421000088 Filed on January 14, 2021

View on sec.gov

Income Statement

Concept 2020 Q4
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $840.0K
YoY Change 25.37%
% of Gross Profit
Research & Development $595.0K
YoY Change -11.19%
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $1.436M
YoY Change 7.16%
Operating Profit -$1.436M
YoY Change
Interest Expense $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $1.000K
YoY Change
Pretax Income -$1.430M
YoY Change 9.16%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.435M
YoY Change 9.85%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$139.9K
COMMON SHARES
Basic Shares Outstanding 15.11M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.390M
YoY Change 119.29%
Cash & Equivalents $5.783M
Short-Term Investments
Other Short-Term Assets $110.0K
YoY Change 22.22%
Inventory
Prepaid Expenses $111.1K
Receivables
Other Receivables
Total Short-Term Assets $7.500M
YoY Change 113.68%
LONG-TERM ASSETS
Property, Plant & Equipment $185.00
YoY Change -69.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.040M
YoY Change 0.0%
TOTAL ASSETS
Total Short-Term Assets $7.500M
Total Long-Term Assets $2.040M
Total Assets $9.540M
YoY Change 71.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $470.0K
YoY Change -17.54%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $490.0K
YoY Change -15.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $490.0K
Total Long-Term Liabilities $0.00
Total Liabilities $490.0K
YoY Change -15.52%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $15.11K
YoY Change 341.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.435M
YoY Change
Total Liabilities & Shareholders Equity $9.540M
YoY Change 71.96%

Cashflow Statement

Concept 2020 Q4
OPERATING ACTIVITIES
Net Income -$1.435M
YoY Change 9.85%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$1.320M
YoY Change 25.71%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.579M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $6.579M
YoY Change -65890.0%
NET CHANGE
Cash From Operating Activities -$1.320M
Cash From Investing Activities $0.00
Cash From Financing Activities $6.579M
Net Change In Cash $5.259M
YoY Change -601.2%
FREE CASH FLOW
Cash From Operating Activities -$1.320M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
111055 USD
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
195127 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
185 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
246 USD
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
11552 USD
CY2020Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
11959 USD
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
15112 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
4992 USD
CY2020Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
10500 USD
CY2019Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
586 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
47527 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
63762 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
5461213 USD
CY2020Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
567 USD
CY2020Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6578553 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
40868 USD
CY2020Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7590000 USD
CY2020Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
696 USD
CY2019Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
4334 USD
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10500 USD
CY2020Q4 artl Unamortized Value Of Stock Based Compensation
UnamortizedValueOfStockBasedCompensation
23333 USD

Files In Submission

Name View Source Status
0001640334-21-000088-index-headers.html Edgar Link pending
0001640334-21-000088-index.html Edgar Link pending
0001640334-21-000088.txt Edgar Link pending
0001640334-21-000088-xbrl.zip Edgar Link pending
artl-20201130.xml Edgar Link completed
artl-20201130.xsd Edgar Link pending
artl-20201130_cal.xml Edgar Link unprocessable
artl-20201130_def.xml Edgar Link unprocessable
artl-20201130_lab.xml Edgar Link unprocessable
artl-20201130_pre.xml Edgar Link unprocessable
artl_10q.htm Edgar Link pending
artl_ex311.htm Edgar Link pending
artl_ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending